Latest Ratios: P/E Ratio -6.8x · EV/EBITDA 16.9x · ROE -9.0%. (2000–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.9B | $1.7B | $3.1B | $4.5B | $5.6B | $7.7B | $5.6B | $5.6B | $4.7B | $8.1B | $4.6B |
| Enterprise Value | $4.2B | $4.0B | $5.0B | $6.0B | $7.0B | $8.6B | $6.6B | $7.9B | $6.6B | $9.9B | $8.4B |
| P/E Ratio → | -6.80 | — | — | 44.09 | 12.11 | 7.39 | 19.19 | 12.99 | 13.88 | 12.75 | 14.03 |
| P/S Ratio | 0.33 | 0.30 | 0.51 | 0.73 | 0.70 | 1.01 | 0.93 | 0.82 | 0.50 | 0.97 | 0.47 |
| P/B Ratio | 0.63 | 0.58 | 0.98 | 1.28 | 1.45 | 1.69 | 1.52 | 1.97 | 1.70 | 2.41 | 2.78 |
| P/FCF | 16.23 | 14.88 | 39.28 | — | 8.69 | 12.34 | 1394.64 | 8.94 | 5.21 | 8.67 | 6.87 |
| P/OCF | 6.51 | 5.97 | 11.80 | 21.33 | 6.10 | 8.11 | 22.05 | 6.21 | 3.86 | 6.66 | 4.21 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.71 | 0.83 | 0.98 | 0.88 | 1.12 | 1.09 | 1.16 | 0.71 | 1.19 | 0.86 |
| EV / EBITDA | 16.89 | 16.25 | 18.94 | 16.54 | 7.40 | 8.55 | 9.18 | 10.64 | 5.14 | 8.50 | 8.65 |
| EV / EBIT | — | — | 125.00 | 36.50 | 9.29 | 6.57 | 15.53 | 15.66 | 7.82 | 12.25 | 12.33 |
| EV / FCF | — | 34.75 | 63.29 | — | 10.98 | 13.78 | 1642.39 | 12.62 | 7.43 | 10.62 | 12.52 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 13.2% | 13.2% | 14.3% | 14.8% | 19.3% | 20.7% | 18.3% | 20.3% | 21.6% | 21.7% | 17.4% |
| Operating Margin | -0.7% | -0.7% | -0.4% | 1.4% | 8.4% | 9.5% | 7.2% | 6.9% | 11.1% | 10.2% | 6.7% |
| Net Profit Margin | -4.8% | -4.8% | -3.1% | 1.7% | 5.7% | 13.6% | 17.2% | 8.3% | 3.6% | 7.6% | 3.4% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -9.0% | -9.0% | -5.7% | 2.8% | 11.0% | 25.4% | 31.8% | 20.2% | 11.0% | 25.3% | 18.8% |
| ROA | -3.9% | -3.9% | -2.6% | 1.3% | 5.2% | 11.5% | 12.1% | 6.9% | 3.7% | 6.5% | 3.4% |
| ROIC | -0.6% | -0.6% | -0.4% | 1.2% | 9.4% | 10.8% | 6.6% | 7.1% | 15.7% | 12.0% | 8.3% |
| ROCE | -0.7% | -0.7% | -0.4% | 1.3% | 9.7% | 10.4% | 6.6% | 7.4% | 15.6% | 11.8% | 8.4% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.92 | 0.92 | 0.71 | 0.59 | 0.55 | 0.43 | 0.70 | 1.00 | 0.84 | 0.68 | 2.55 |
| Debt / EBITDA | 11.02 | 11.02 | 8.47 | 5.71 | 2.23 | 1.93 | 3.61 | 3.81 | 1.79 | 1.96 | 4.35 |
| Net Debt / Equity | — | 0.78 | 0.60 | 0.44 | 0.38 | 0.20 | 0.27 | 0.81 | 0.72 | 0.54 | 2.29 |
| Net Debt / EBITDA | 9.29 | 9.29 | 7.19 | 4.22 | 1.54 | 0.90 | 1.38 | 3.10 | 1.53 | 1.56 | 3.91 |
| Debt / FCF | — | 19.87 | 24.01 | — | 2.29 | 1.44 | 247.75 | 3.68 | 2.21 | 1.95 | 5.65 |
| Interest Coverage | -0.49 | -0.49 | 0.51 | 2.52 | 12.24 | 19.60 | 4.92 | 4.52 | 7.38 | 4.92 | 3.35 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.30 | 1.30 | 1.36 | 1.97 | 1.85 | 1.92 | 1.80 | 1.87 | 1.84 | 1.83 | 2.00 |
| Quick Ratio | 0.78 | 0.78 | 0.77 | 1.23 | 1.26 | 1.41 | 1.37 | 1.41 | 1.13 | 1.50 | 1.24 |
| Cash Ratio | 0.27 | 0.27 | 0.22 | 0.46 | 0.38 | 0.51 | 0.80 | 0.26 | 0.21 | 0.14 | 0.24 |
| Asset Turnover | — | 0.81 | 0.85 | 0.84 | 0.98 | 0.82 | 0.69 | 0.82 | 1.18 | 0.82 | 1.05 |
| Inventory Turnover | 6.03 | 6.03 | 5.64 | 6.00 | 6.51 | 5.86 | 5.80 | 5.92 | 6.49 | 6.10 | 5.94 |
| Days Sales Outstanding | — | 43.48 | 43.84 | 44.98 | 37.94 | 64.15 | 55.19 | 51.18 | 46.04 | 56.03 | 44.71 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 7.8% | 8.5% | 5.6% | 3.8% | 3.1% | 2.1% | 2.6% | 2.7% | 3.3% | 1.5% | 2.6% |
| Payout Ratio | — | — | — | 167.3% | 37.2% | 15.2% | 13.9% | 26.7% | 46.3% | 18.9% | 36.8% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | 2.3% | 8.3% | 13.5% | 5.2% | 7.7% | 7.2% | 7.8% | 7.1% |
| FCF Yield | 6.2% | 6.7% | 2.5% | — | 11.5% | 8.1% | 0.1% | 11.2% | 19.2% | 11.5% | 14.6% |
| Buyback Yield | 0.2% | 0.2% | 0.1% | 7.8% | 18.0% | 2.6% | 1.7% | 3.7% | 5.9% | 0.0% | 0.1% |
| Total Shareholder Yield | 8.0% | 8.6% | 5.7% | 11.6% | 21.1% | 4.6% | 4.3% | 6.4% | 9.3% | 1.5% | 2.7% |
| Shares Outstanding | — | $173M | $172M | $177M | $203M | $221M | $222M | $231M | $242M | $244M | $240M |
Cyclical MDI margin compression
According to recent market data, Huntsman trades at a P/S ratio of 0.35, which reflects deep investor skepticism regarding the company's ability to return to historical profitability levels given the current negative net margin and persistent headwinds in the global MDI market.
The current P/E of -7.18 and P/B of 0.67 suggest that the market is pricing the company as a distressed asset rather than a specialty chemical player. Investors should monitor whether the forward EV/EBITDA of 7.22 represents a genuine recovery opportunity or a value trap, as the valuation implies that any meaningful earnings rebound remains contingent on a cyclical upturn that has yet to materialize.
Based on reported financial statements, Huntsman's ROIC has trended into negative territory, reaching -0.2% in 2026Q1, which indicates that the company is currently failing to generate returns that exceed its cost of capital during this prolonged industrial downturn.
The consistent decay in ROIC from positive levels in 2024Q3 to recent negative readings suggests that the company's capital-intensive manufacturing base is becoming a liability rather than a source of competitive advantage. This trend warrants further investigation into whether the current asset base can ever achieve historical return thresholds without significant further restructuring or a sustained recovery in global industrial demand.
As reported in quarterly filings, Huntsman's cash conversion cycle has remained elevated, fluctuating between 51 and 68 days over the last ten quarters, which highlights the company's ongoing struggle to optimize inventory and receivables in a volatile demand environment.
The persistent DIO levels, which reached 72 days in 2025Q1, suggest that the company is carrying significant inventory risk that ties up liquidity during periods of weak sales. Investors should monitor the DSO and DPO trends, as any inability to tighten these metrics will likely continue to pressure free cash flow and limit the company's operational flexibility.
Data from recent SEC filings indicates that Huntsman's debt-to-equity ratio has climbed to 0.92, reflecting a deteriorating balance sheet as the company relies on debt to bridge the gap created by persistent net losses and negative operating margins.
The lack of consistent positive interest coverage, evidenced by the -0.76 ratio in 2026Q1, suggests that the company's debt service capacity is becoming increasingly fragile. This leverage profile appears to be a structural concern, as the company lacks the earnings buffer to comfortably manage its debt obligations if the current cyclical trough persists longer than anticipated.
The P/E ratio is frequently misapplied to Huntsman, as the company's heavy reliance on cyclical MDI pricing and significant non-cash charges often render GAAP earnings an unreliable indicator of the firm's underlying cash-generating potential.
Investors should instead focus on EV/EBITDA and free cash flow yield to better assess the company's operational performance, as these metrics strip away the noise of accounting impairments and capital structure shifts. Relying on P/E in a cyclical downturn for a company with negative net margins obscures the true cash-flow-generating capacity of the core specialty segments.
Includes 30+ ratios · 26 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying HUN stock.
Huntsman Corporation's current P/E ratio is -6.8x. The historical average is 25.7x.
Huntsman Corporation's current EV/EBITDA is 16.9x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 9.6x.
Huntsman Corporation's return on equity (ROE) is -9.0%. The historical average is 11.1%.
Based on historical data, Huntsman Corporation is trading at a P/E of -6.8x. Compare with industry peers and growth rates for a complete picture.
Huntsman Corporation's current dividend yield is 7.82%.
Huntsman Corporation has 13.2% gross margin and -0.7% operating margin.
Huntsman Corporation's Debt/EBITDA ratio is 11.0x, indicating high leverage. A ratio above 4x may signal elevated financial risk.